-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Overweight on United Therapeutics, Raises Price Target to $525

Benzinga·09/10/2025 13:04:57
Listen to the news
Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $405 to $525.